PATENT CLAIM ANALYSIS

Application Number: 16136804
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "183000"]

Abstract:
Roflumilast crystals have been shown to increase in size during storage. The size of the roflumilast crystals can affect the bioavailability and efficacy of a pharmaceutical composition. The growth of roflumilast crystals can be inhibited during storage by including hexylene glycol in the composition. The resulting composition has improved bioavailability and efficacy and can be used to inhibit phosphodiesterase 4 in a patient in need of such treatment.

Claim (Index 4):
The method according to  claim 1 , wherein said hexylene glycol is added in an amount of 0.1-20% w/w.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15676373', '15848462', '15616409', '15848505', '14106265']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8122219440471957
- 35 USC 102 Novelty (BERT): 0.6449673597815728
- Combined Prediction Score: 0.7954964856206335
- Mean Citation Score: 507.78543800000006
- Max Citation Score: 600.16254
- Similarity Product: 577.7027557961403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test